Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3545061 | 0.87 | — | — | |
| SCHEMBL3549088 | 0.85 | — | — | |
| SCHEMBL5605998 | 0.72 | CYP1A2 (0.39) | CYP1A2 | |
| SCHEMBL4188287 | 0.69 | CNR1 (0.31) | — | |
| SCHEMBL3542431 | 0.69 | CYP1A2 (0.33) | CYP1A2 | |
| SCHEMBL11051165 | 0.68 | CNR1 (0.33) | — | |
| SCHEMBL10779865 | 0.68 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL6318304 | 0.68 | CYP1A2 (0.40) | CYP1A2 | |
| SCHEMBL3538657 | 0.68 | ALDH1A1 (0.30) | — | |
| SCHEMBL21342878 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101087772-B | High-purity alicyclic diepoxy compound and preparation method thereof | DAICEL CHEM | 2012-05-09 | — | — | CN | disclosed |
| CN-1934098-B | High-purity alicyclic epoxy compound, process for producing the same, curable epoxy resin composition, cured article thereof, and use | DAICEL CHEM | 2012-04-25 | — | — | CN | disclosed |
| US-7732627-B2 | High-purity cycloaliphatic diepoxy compound and preparation process thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2010-06-08 | — | — | US | disclosed |
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1834949-A1 | HIGH-PURITY ALICYCLIC DIEPOXY COMPOUND AND PROCESS FOR PRODUCING THE SAME | Daicel Chemical Industries, Ltd. (JP) | 2007-09-19 | — | — | EP | disclosed |
| US-20070179256-A1 | High-purity alicyclic epoxy compound, process for production of the same, curable epoxy resin composition, cured product thereof, and application thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2007-08-02 | — | — | US | disclosed |
| CN-1934098-A | High-purity alicyclic epoxy compound, process for producing the same, curable epoxy resin composition, cured article thereof, and use | DAICEL CHEM (JP) | 2007-03-21 | — | — | CN | disclosed |
| EP-1726588-A1 | HIGH-PURITY ALICYCLIC EPOXY COMPOUND, PROCESS FOR PRODUCING THE SAME, CURABLE EPOXY RESIN COMPOSITION, CURED ARTICLE THEREOF, AND USE | Daicel Chemical Industries, Ltd. (JP) | 2006-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080045729-A1 | High-Purity Cycloaliphatic Diepoxy Compound and Preparation Process Thereof | DUOX2, SQLE, HPD | CYP1A2 434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.